XML 79 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2013
Jun. 30, 2012
CURRENT ASSETS:    
Cash and cash equivalents $ 9,007 $ 9,389
Short term bank deposits 31,449 21,397
Restricted cash and restricted short term deposits 316   
Marketable securities 13,441 7,023
Other current assets 872 383
Total current assets 55,085 38,192
LONG-TERM ASSETS:    
Long-term deposits and restricted deposits 421 1,287
Severance pay fund 905 522
Advance payment for leasehold improvements    2,400
Property and equipment, net 11,866 5,019
Other long term assets 39   
Total long-term assets 13,231 9,228
Total assets 68,316 47,420
CURRENT LIABILITIES    
Trade payables 2,837 1,368
Accrued expenses 1,040 922
Deferred revenues 379 779
Advance payment from United Therapeutics 393 1,576
Other accounts payable 1,272 877
Total current liabilities 5,921 5,522
LONG-TERM LIABILITIES    
Deferred revenues 3,226 3,505
Accrued severance pay 1,023 651
Other long term liabilities 680   
Total long term liabilities 4,929 4,156
COMMITMENTS AND CONTINGENCIES      
STOCKHOLDERS' EQUITY    
Share capital: Common stock $0.00001 par value: Authorized: 100,000,000 shares Issued and outstanding: 59,196,617 shares as of June 30, 2013, 46,448,051 shares as of June 30, 2012      
Additional paid-in capital 144,109 103,619
Accumulated deficit (86,902) (65,747)
Other comprehensive (loss) income 259 (130)
Total stockholders' equity 57,466 37,742
Total liabilities and stockholders' equity $ 68,316 $ 47,420